食管覆膜支架置入治疗恶性肿瘤所致的食管气管瘘21例  

Treatment of malignant esophagorespiratory fistula with metallic stents:An analysis of 21 cases

作　　者：王宝明[1,2] 杨海山[1] 

机构地区：[1]吉林大学第三临床医院放射科,吉林省长春市130021 [2]中国医科大学附属第四医院放射科,辽宁省沈阳市110032

出　　处：《世界华人消化杂志》2013年第6期527-530,共4页World Chinese Journal of Digestology

摘　　要：目的:观察与评价金属覆膜支架置入治疗食管气管瘘的疗效.方法:21例食管气管瘘患者,术前伴明显的肺部感染、营养不良及进食呛咳等症状,在DSA导引下经口置入金属覆膜支架,观察支架置入疗效和并发症等指标.结果:21例患者成功置入支架21枚,支架置入术后患者进食困难均有改善,肺部感染得到明显控制,支架置入后患者KPS评分由40.0±10.8增加至70.3±14.0(P<0.01),随访平均生存时间30wk(4-80wk).结论:DSA导引下金属覆膜支架置入术对食管气管瘘患者是有效、安全的治疗手段,能改善症状,提高患者的生存质量,延长生存时间.AIM： To assess the efficacy and safety of metallic stent implantation in the treatment of malignant esophagorespiratory fistula. METHODS： Twenty-one nant esophagorespiratory patients with maligfistula were included in this study. They had pulmonary infection, dystrophia and choke before stent implantation. The stent was introduced under DSA guidance. The success rate, complication rate and curative effect were observed. RESULTS： Stents were placed successfully in 21 patients. Dysphagia was relieved and the food intake ability was improved in all 21 patients. The mean KPS increased significantly from 40.0 ± 10.8 before stent placement to 70.3 ± 14.0 one week after placement （P 〈 0.01）. The median survive time was 30 weeks. CONCLUSION： Stent implantation under DSA guidance is a safe and effective treatment for malignant esophagorespiratory fistula, and it can improve patients＇ life quality and clinical symptoms.

关 键 词：金属支架 食管气管瘘 

分 类 号：R735.1[医药卫生—肿瘤]